MarketInOut Stock Screener Log In | Sign Up

Cyclopharm Ltd

Healthcare • Medical Devices • Quote as of 10/29/2026 16:10
Cyclopharm Ltd stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
Market Capitalization47.15 mln
Float64.48 mln
Earnings Date02/24/2027

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.47
Reliable

1-Year Forecast

1.02
Transformational upside

Relative Strength

7 / 100
Severely lagging

Debt / Equity

0.25
Very low leverage

Pre-Tax Margin

-54%
Severely loss-making

Business Description

Founded in 1986 and based in Kingsgrove, Australia, Cyclopharm Limited develops and sells specialized medical tools and radioactive compounds used in diagnosing lung conditions such as pulmonary embolism. Its core product, Technegas, is a widely used system that helps doctors in nuclear medicine departments detect respiratory problems accurately. The company sells its products across Asia Pacific, Europe, Canada, the United States, and other markets, while also distributing third-party diagnostic imaging products and conducting ongoing research and development.

Key Fundamentals

EPS-0.16
ROE-57.82
RPS0.30
ROIC-51.81
ROA-36.24
Interest Cover-30.10
EBITDA, mln-16.44
EV / EBITDA-3.03
EV / EBIT-2.75
Revenue, mln34.42
EV / Revenue1.45

Quote Details

Last 0.385
Change 0.015 (4.05%)
Open 0.375
Volume 138,069
Turnover 53,157
Average Volume 106,561

Financial Ratios

Pre-Tax Profit Margin-54
Leverage Ratio1.56
Current Ratio3.37
Price / Book1.80
Price / Tangible Book1.98
Debt / Equity0.25
Price / Sales1.53

Financial Strength

Altman Z-Score-0.33
Piotroski F-Score 3 / 9
Beneish M-Score-3.47
1-Year Target Price1.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.05% 84 / 100   
1 Month -15.38% 24 / 100   
2 Months -31.86% 11 / 100   
6 Months -46.9% 12 / 100   
1 Year -41.22% 23 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog